共 57 条
[1]
(1916)
[2]
(1919)
[3]
(1974)
[4]
(1974)
[5]
Jaffe J.H., O'Keeffe C.O., From morphine clinics to buprenorphine: Regulating opioid agonist treatment of addiction in the United States, Drug Alcohol Depend, 70, SUPPL., (2003)
[6]
Heel R.C., Brogden R.N., Speight T.M., Avery G.S., Buprenorphine: A review of its pharmacological properties and therapeutic efficacy, Drugs, 17, pp. 81-110, (1979)
[7]
Jasinski D.R., Pevnick J.S., Griffith J.D., Human pharmacology and abuse potential of the analgesic buprenorphine: A potential agent for treating narcotic addiction, Arch. Gen. Psychiatry, 35, pp. 501-516, (1978)
[8]
Martin W.R., Eades C.G., Thompson J.A., Et al., The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog, J. Pharmacol. Exp. Ther., 197, pp. 517-532, (1976)
[9]
Villiger J.W., Taylor K.M., Buprenorphine: Characteristics of binding sites in the rat central nervous system, Life Sci., 29, pp. 2699-2708, (1981)
[10]
Sadee W., Richards M.L., Grevel J., Rosenbaum J.S., In vivo characterization of four types of opioid binding sites in rat brain, Life Sci., 33, pp. 187-189, (1983)